Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
Iron Butte
Gold Stocks Mining Stocks Rare Earths Stocks Resources Silver stocks
Great Northern Minerals (ASX:GNM): The Acquisition of The Iron Butte Gold-Silver Project In Nevada Is Cause For Optimism!
Great Northern Minerals (ASX:GNM) has spent the past year reshaping itself into a more credible, more diversified US‑focused explorer, with the acquisition of the Iron Butte gold‑silver project in Nevada. This is in addition to the Catalyst Ridge critical‑minerals system in California’s Mountain Pass district.Both matter, but one now defines the investment case. Iron Butte,…
May 4, 20260Comments
ASX Biotech Success Stories
Biotech Stocks Growth Stocks Healthcare Stocks Life Sciences
Here Are 5 Of The Biggest ASX Biotech Success Stories! And 5 Of The Biggest Disasters!
For every one of the ASX Biotech Success Stories, there are several failures. While a handful of companies can and do convert clinical data into extraordinary value, many others run into the barrier that decides everything: the primary endpoint.The successes tend to follow a recognisable pattern — a credible clinical signal, external validation, and either…
May 4, 20260Comments
asx companies
Small Caps Stocks Growth Stocks
Here’s How ASX Companies Become 10-Baggers And How Investors Can Identify Top Candidates To Be Next!
Every investor eyeing off ASX companies will desire to find a 10‑bagger. Very few work with a structure that makes it repeatable. Yet these moves are not random. In our experience, they follow a recognisable sequence, and the ASX has offered clean examples over the past year in companies like 4D Medical, Sunrise Energy Minerals…
May 1, 20260Comments
tungsten
Mining Stocks Small Caps Stocks
Tungsten: Its A Metal Whose Moment Has Arrived And These 3 ASX Stocks Are Exposed To It!
Tungsten has quietly become one of the most strategically significant metals in the world. China controls roughly 80% of global supply, yet Beijing has spent the past 18 months systematically restricting exports, and the consequences for Western industrial and defence supply chains are now acute.Prices are at all-time highs, the supply-demand deficit is structural rather…
May 1, 20260Comments
Shares in Dimerix
Biotech Stocks Healthcare Stocks Life Sciences
Shares In Dimerix (ASX:DXB) Fell 40% Today; Not About The Data, But About the Timing
Shares in Dimerix fell over 35% this morning and some may think the decline was irrational. After all, the announcement confirmed >90 per cent statistical power for its primary endpoint, reminded the market that its 2024 futility analysis showed the drug outperforming placebo, and reported no safety issues across seven IDMC reviews. On paper, that…
April 28, 20260Comments
Percheron
Biotech Stocks Healthcare Stocks Life Sciences
Percheron Therapeutics (ASX:PER): An Oncology Biotech That’s Growing Its Footprint
Percheron Therapeutics is not the kind of company that typically commands market attention at a A$6–7m valuation. Yet the more one looks at its trajectory over the past twelve months, the more it becomes clear that the market is missing something important. The company has moved from being a near‑dormant shell to a clinical‑stage immuno‑oncology…
April 28, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here